Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Rogers (ROG) Shares Outstanding (Diluted Average) (2016 - 2026)

Rogers has reported Shares Outstanding (Diluted Average) over the past 17 years, most recently at $17.9 million for Q1 2026.

  • For Q1 2026, Shares Outstanding (Diluted Average) fell 3.24% year-over-year to $17.9 million; the TTM value through Mar 2026 reached $17.9 million, down 3.24%, while the annual FY2025 figure was $18.2 million, 2.15% down from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 was $17.9 million at Rogers, down from $18.2 million in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $19.0 million in Q4 2022 and troughed at $17.9 million in Q1 2026.
  • A 5-year average of $18.6 million and a median of $18.6 million in 2023 define the central range for Shares Outstanding (Diluted Average).
  • Biggest five-year swings in Shares Outstanding (Diluted Average): grew 1.2% in 2022 and later fell 3.24% in 2026.
  • Year by year, Shares Outstanding (Diluted Average) stood at $19.0 million in 2022, then decreased by 1.58% to $18.7 million in 2023, then fell by 0.53% to $18.6 million in 2024, then decreased by 2.15% to $18.2 million in 2025, then fell by 1.65% to $17.9 million in 2026.
  • Business Quant data shows Shares Outstanding (Diluted Average) for ROG at $17.9 million in Q1 2026, $18.2 million in Q4 2025, and $18.3 million in Q3 2025.